ResearcherSun Yat-sen UniversityNo recent work listed
Kebing Wang
Matched on ORCID iD 0009-0009-8212-769X; OpenAlex author ID A5039120969. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 paper
Papers 3
- GOLPH3 Promotes Cancer Growth by Interacting With STIP1 and Regulating Telomerase Activity in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fonc.2020.575358↗
- Upregulation of macrophage migration inhibitory factor promotes tumor metastasis and correlates with poor prognosis of pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/or.2018.6703↗
- Overexpression of GOLPH3 is associated with poor prognosis and clinical progression in pancreatic ductal adenocarcinoma. First author DOI 10.1186/1471-2407-14-571↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Meifang He · 2 shared papers, 2018–2020 · strength 0.19
- Paper GOLPH3 Promotes Cancer Growth by Interacting With STIP1 and Regulating Telomerase Activity in Pancreatic Ductal Adenoca… DOI 10.3389/fonc.2020.575358↗
- Paper Upregulation of macrophage migration inhibitory factor promotes tumor metastasis and correlates with poor prognosis of … DOI 10.3892/or.2018.6703↗
- Wen Li Ma · 2 shared papers, 2018–2020 · strength 0.19
- Paper GOLPH3 Promotes Cancer Growth by Interacting With STIP1 and Regulating Telomerase Activity in Pancreatic Ductal Adenoca… DOI 10.3389/fonc.2020.575358↗
- Paper Upregulation of macrophage migration inhibitory factor promotes tumor metastasis and correlates with poor prognosis of … DOI 10.3892/or.2018.6703↗
- Zhi Li · 2 shared papers, 2014–2020 · strength 0.15
- Paper GOLPH3 Promotes Cancer Growth by Interacting With STIP1 and Regulating Telomerase Activity in Pancreatic Ductal Adenoca… DOI 10.3389/fonc.2020.575358↗
- Paper Overexpression of GOLPH3 is associated with poor prognosis and clinical progression in pancreatic ductal adenocarcinoma. DOI 10.1186/1471-2407-14-571↗
- Dong Wang · 1 shared paper, 2018 · strength 0.09
- Luanjing Zhang · 1 shared paper, 2014 · strength 0.04
- Xia Jing-tang · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.